LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples.

Mohammadjavad Karimi TaheriSogol GhanbariAkram GholipourTaraneh GiviMajid Sadeghizadeh

Published in: Cancer reports (Hoboken, N.J.) (2023)

In conclusion, our results suggest that LINC01116 can be a potential biomarker in distinguishing ER+ and ER- tissues and has different effects on patients' survival based on ER status by affecting TGF-β and ER signaling.

Keyphrases

endoplasmic reticulum
estrogen receptor
breast cancer cells
long non coding rna
ejection fraction
end stage renal disease
chronic kidney disease
case report
free survival
young adults
patient reported